<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-12044092</id><updated>2011-04-21T14:12:11.381-07:00</updated><title type='text'>DRUGS FOR THE TREATMENT OF VIRAL DISEASES</title><subtitle type='html'></subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://viraltreatment.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/12044092/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://viraltreatment.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>Testimonials - Kriger Clinical Research Training</name><uri>http://www.blogger.com/profile/16932401722162313285</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>1</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-12044092.post-111305859054680083</id><published>2005-04-09T07:55:00.000-07:00</published><updated>2005-04-09T07:56:30.563-07:00</updated><title type='text'>DRUGS FOR THE TREATMENT OF VIRAL DISEASES</title><content type='html'>This article has been published by the International Biopharmaceutical Association &lt;a href="http://www.ibpassociation.org/"&gt;www.ibpassociation.org&lt;/a&gt;  . Please note this article does not give any medical advice.&lt;br /&gt;&lt;br /&gt;The project is sponsored by KRC CRO and training services ( &lt;a href="http://www.kriger.com/"&gt;www.kriger.com&lt;/a&gt;  ) and ClinQua CRO (&lt;a href="http://www.clinqua.com/"&gt;www.clinqua.com&lt;/a&gt;  )&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.kriger.com/training/"&gt;Start your Clinical Research Career Now&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;  Acyclovir and valacyclovir&lt;br /&gt;1.      Acts against herpes simplex viruses type 1 and 2 (HSV-1, HSV-2); is also some activity against herpes zoster virus (HSV-3).&lt;br /&gt;2.      Valacyclovir is a prodrug that yields acyclovir.&lt;br /&gt;3.      Mode of action – inhibition of viral DNA synthesis&lt;br /&gt;4.      Can be administered orally, intravenously or as topical ointment; oral bioavailability is under 30%.  Crosses the placenta and can be found concentrated in breast milk.&lt;br /&gt;5.      Uses&lt;br /&gt;b.      Decreases intensity, duration and frequency of herpes simplex attacks&lt;br /&gt;c.      Topical preparation less effective&lt;br /&gt;d.      Given intravenously as prophylaxis in carriers who receive immunosuppression, for HSV encephalitis and for varicella pneumonia and encephalitis&lt;br /&gt;e.      Valacyclovir has been found useful for the pain of herpes zoster (Chicken Pox), but not post-herpetic neuralgia&lt;br /&gt;6.      Side effects&lt;br /&gt;One.     Acyclovir – minimal side effects – nausea, diarrhea, rash, headache&lt;br /&gt;Two.    Valacyclovir – headache, nausea, diarrhea&lt;br /&gt;7.      Toxic effects&lt;br /&gt;One.     Acyclovir – renal failure, tremor, altered sensorium, delirium, seizures, extrapyramidal signs&lt;br /&gt;Two.    Valacyclovir – kidney damage, thrombocytopenia (in immunocompromised patients)&lt;br /&gt;8.      Interactions&lt;br /&gt;One.     Acyclovir with zidovudine may cause deep lethargy and sleepiness.&lt;br /&gt;Two.    Acyclovir with cyclosporine (or other nephrotoxic drug) has increased risk of nephrotoxicity&lt;br /&gt;Three. Probenecid causes increased activity of acyclovir.&lt;br /&gt;Four.   Acyclovir increases activity of methotrexate.&lt;br /&gt; &lt;br /&gt;Famciclovir and penciclovir&lt;br /&gt;1.      Famciclovir is a pro-drug of penciclovir.&lt;br /&gt;2.      Same mode of action as acyclovir&lt;br /&gt;3.      Penciclovir has very low oral bioavailability; famciclovir can be given orally with better results&lt;br /&gt;4.      Uses – herpes zoster in immunocompromised adults&lt;br /&gt;5.      Side effects – headache, diarrhea, nausea&lt;br /&gt;6.      Toxic effects – may increase risk of tumor and cause mutations&lt;br /&gt;7.      Interactions – famciclovir increases concentrations of digoxin&lt;br /&gt; &lt;br /&gt;Foscarnet&lt;br /&gt;1.      Acts by inhibiting synthesis of viral nucleic acids – works on DNA polymerase (of the herpes viruses) or reverse transcriptase (of the HIV virus)&lt;br /&gt;2.      Oral &lt;a href="http://www.krctraining.com/CRA%20Definitions/Bioavailability.htm"&gt;bioavailability &lt;/a&gt;is low; also given intravenously&lt;br /&gt;3.      Uses&lt;br /&gt;One.     cyto-megalo virus (CMV) retinitis and other CMV infections&lt;br /&gt;Two.    CMV resistant to ganciclovir&lt;br /&gt;Three. HSV resistant to acyclovir&lt;br /&gt;4.      Side effects – headache, tremor, seizures, hallucinations, irritability, fever, nausea, vomiting, leukopenia, genital ulcers and changes in liver function tests.&lt;br /&gt;5.      Toxic effects –  clinical hypocalcemia, acute tubular necrosis, interstitial nephritis&lt;br /&gt;6.      Interactions – when given with pentamidine, risk of hypocalcemia is increased&lt;br /&gt; &lt;br /&gt;Ganciclovir&lt;br /&gt;1.      Inhibits synthesis of viral DNA&lt;br /&gt;2.      Especially effective against CMV&lt;br /&gt;3.      Low oral bioavailability; given orally or intravenously&lt;br /&gt;4.      Uses&lt;br /&gt;One.     Treatment of CMV &lt;a href="http://www.krctraining.com/CRA%20Definitions/retinitis.htm"&gt;retinitis &lt;/a&gt;&lt;br /&gt;Two.    Prophylaxis of CMV infection in immunocompromised patients&lt;br /&gt;5.      Side effects – headache, phlebitis, rash, anemia, fever, nausea, vomiting, changes in liver function tests&lt;br /&gt;6.      Toxic effects – bone marrow suppression, convulsions, coma&lt;br /&gt;7.      Interactions&lt;br /&gt;One.     Risk of bone marrow suppression increased with concurrent use of zidovudine, nephrotoxic drugs and cytotoxic drugs&lt;br /&gt;Two.    Probenecid decreases clearance of ganciclovir.&lt;br /&gt; &lt;br /&gt;Zidovudine&lt;br /&gt;1.      Inhibits reverse transcriptase by competing with thymidine; inhibits retroviruses&lt;br /&gt;2.      Good oral absorption and bioavailability&lt;br /&gt;3.      Uses&lt;br /&gt;One.     in HIV positive patients with CD4 counts of under 500/mm3&lt;br /&gt;Two.    in pregnant women with AIDS and their neonates to prevent vertical transmission&lt;br /&gt;4.       Major problem with zidovudine is that there is tolerance after about a year&lt;br /&gt;5.      Side effects – bad headache, nausea, vomiting, difficulties in sleeping, muscle aches&lt;br /&gt;6.      Safety in pregnancy not completely clear – neonates show anemia and growth retardation, but no excess malformations found&lt;br /&gt;7.      Toxic effects – granulocytopenia and anemia&lt;br /&gt;8.      Interactions&lt;br /&gt;One.     Increased risk of bone marrow suppression with fluconazole, ganciclovir or probenecid&lt;br /&gt;Two.    Reduced consciousness may occur with acyclovir.&lt;br /&gt;Three. Clarithromycin decreases absorption of zidovudine.&lt;br /&gt;Four.   Rifampin may decrease concentration of zidovudine.&lt;br /&gt; &lt;br /&gt;Didanosine&lt;br /&gt;1.      Acts via competitive inhibition of reverse transcriptase&lt;br /&gt;2.      Given orally, regular or buffered tablet,  or intravenously&lt;br /&gt;3.      Uses – advanced HIV infection after at least 4 months of zidovudine&lt;br /&gt;4.      Side effects – diarrhea, rash, headache, seizures, difficulty sleeping, optic neuritis, loss of retinal pigmentation in children, &lt;a href="http://www.krctraining.com/CRA%20Definitions/hyperuricemia.htm"&gt;hyperuricemia&lt;/a&gt;&lt;br /&gt;5.      Toxic effects – peripheral neuropathy, pancreatitis&lt;br /&gt;6.      Interactions –  buffered tablet can decrease absorption of  ketoconazole, dapsone, tetracycline, quinolones&lt;br /&gt; &lt;br /&gt;Stavudine&lt;br /&gt;1.      Competitive inhibition of reverse transcriptase&lt;br /&gt;2.      Well-absorbed orally&lt;br /&gt;3.      Uses – in AIDS where other agents have not helped&lt;br /&gt;4.      Side effects – anemia, arthralgia, rash, fever&lt;br /&gt;5.      Toxic effects – peripheral sensory neuropathy, elevated liver enzymes&lt;br /&gt;6.      Interactions - avoid giving with didanosine or zalcitabine because of increased risk of neuropathy.&lt;br /&gt; &lt;br /&gt;Zalcitabine&lt;br /&gt;1.      Competitive inhibition of reverse transcriptase&lt;br /&gt;2.      High oral bioavailability; also given intravenously&lt;br /&gt;3.      Uses&lt;br /&gt;One.     Together with zidovudine for AIDS patients with CD4 under 300/mm3&lt;br /&gt;Two.    For AIDS patients intolerant to zidovudine&lt;br /&gt;4.      Side effects – fever, nausea, rash, headache,  mouth ulcers, granulocytopenia&lt;br /&gt;5.      Toxic effects – peripheral neuropathy&lt;br /&gt;6.      Interactions – avoid use of didanosine and stavudine.&lt;br /&gt; &lt;br /&gt;Amantadine and rimantadine&lt;br /&gt;1.      Inhibit replication of influenza A viruses&lt;br /&gt;2.      Good oral absorption&lt;br /&gt;3.      Uses – treatment and prophylaxis of influenza A; amantadine is also used in Parkinson’s disease&lt;br /&gt;4.      Side effects – nausea, anorexia, nervousness, lack of concentration, difficulty sleeping&lt;br /&gt;5.      Toxic effects of amantadine - delirium, hallucinations, seizures, coma, arrhythmias, worsening of psychiatric problems and epilepsy&lt;br /&gt;6.      Interactions – toxic effects on the &lt;a href="http://www.krctraining.com/CRA%20Definitions/brain.htm"&gt;CNS &lt;/a&gt;worsened by use with antihistamines, neuroleptic drugs or anticholinergic drugs&lt;br /&gt; &lt;br /&gt;Interferons&lt;br /&gt;1.      Interferons are cytokines and are divided into a, b, and g interferons.   One of their functions is in increasing resistance to viruses, either directly or via modulation of the immune response.&lt;br /&gt;2.      Oral bioavailability is nil; intramuscular or subcutaneous administration is effective.&lt;br /&gt;3.      Uses&lt;br /&gt;One.     Human papilloma virus – genital warts&lt;br /&gt;Two.    Chronic hepatitis B and C&lt;br /&gt;Three. Multiple sclerosis&lt;br /&gt;Four.   Kaposi’s sarcoma&lt;br /&gt;4.      Side effects – flu-like syndrome, elevated liver enzymes, interstitial nephritis, proteinuria, hair loss&lt;br /&gt;5.      Toxic effects – myelosuppression, sleepiness, confusion, fatigue, weight loss, thyroid problems and cardiac damage&lt;br /&gt;6.      Interactions – increases myelotoxicity of zidovudine&lt;br /&gt; &lt;br /&gt;Ribavirin&lt;br /&gt;1.      Inhibits synthesis of viral m-RNA&lt;br /&gt;2.      Fair oral absorption; also given intravenously, but mostly as aerosol&lt;br /&gt;3.      Uses&lt;br /&gt;a.               Respiratory infections due to RSV (respiratory syncytial virus)&lt;br /&gt;b.               Severe influenza&lt;br /&gt;c.               Parainfluenza and measles in immunocompromised patients&lt;br /&gt;4.      Side effects&lt;br /&gt;One.     Aerosol preparation can cause irritation to the eyes, rash and wheezing.&lt;br /&gt;Two.    Systemic side effects include anemia, elevated bilirubin, iron and uric acid.&lt;br /&gt;5.      Toxic effects – rigors&lt;br /&gt;6.      Ribavirin appears to be &lt;a href="http://www.krctraining.com/CRA%20Definitions/teratogen.htm"&gt;teratogenic&lt;/a&gt;, embryotoxic, oncogenic and gonadotoxic.&lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt;DRUGS FOR THE TREATMENT OF FUNGAL INFECTIONS&lt;br /&gt; &lt;br /&gt;Amphotericin B&lt;br /&gt;1.   Can only be given &lt;a href="http://www.krctraining.com/CRA%20Definitions/parenteral.htm"&gt;parenterally&lt;/a&gt;; new preparations based on liposomes are in use in other countries&lt;br /&gt;2.   Effective against &lt;a href="http://www.krctraining.com/CRA%20Definitions/candida_albicans.htm"&gt;Candida&lt;/a&gt;, Cryptococcus, Blastomyces, Histoplasma, Coccidioides, Aspergillus and mucormycosis&lt;br /&gt;3.   Side effects&lt;br /&gt;a.               Fever and chills are most common.  Also seen are nausea, vomiting, headache, weight loss and phlebitis (inflammation of a vein).&lt;br /&gt;b.               Respiratory distress and a slight fall in blood pressure may occur – this may be serious in patients with cardiac or respiratory disease; best to pretreat such patients with paracetamol/acetaminophen or intravenous hydrocortisone hemisuccinate.&lt;br /&gt;4.   Toxic effects – azotemia is very common and is dose-dependent; renal tubular acidosis and loss of magnesium  and potassium in urine also occur&lt;br /&gt; &lt;br /&gt;Flucytosine&lt;br /&gt;1.   Effective against Cryptococcus, Candida and chromomycosis.&lt;br /&gt;2.   Given orally&lt;br /&gt;3.   Resistance develops quickly and so should not be used as single agent.&lt;br /&gt;4.   Side effects – rash, nausea, vomiting, diarrhea, enterocolitis, transient elevation of liver enzymes&lt;br /&gt;5.   Toxic effects - myelosuppression&lt;br /&gt; &lt;br /&gt;Ketoconazole&lt;br /&gt;1.   Other similar antifungals are clotrimazole, miconazole, econazole, butoconazole and sulconazole.&lt;br /&gt;2.   Effective against Blastomyces, Histoplasma, Coccidioides, ringworm, &lt;a href="http://www.krctraining.com/CRA%20Definitions/tinea_versicolor.htm"&gt;tinea versicolor&lt;/a&gt;, Candida vulvovaginitis, oral and esophageal &lt;a href="http://www.krctraining.com/CRA%20Definitions/candida_albicans.htm"&gt;Candida&lt;/a&gt; and chronic mucocutaneous candidiasis&lt;br /&gt;3.   Given orally; metabolized by &lt;a href="http://www.krctraining.com/CRA%20Definitions/cytochrome_p.htm"&gt;cytochrome P450&lt;/a&gt; and cleared by hepatic &lt;a href="http://www.krctraining.com/CRA%20Definitions/microsome.htm"&gt;microsomal&lt;/a&gt; enzymes.  Can also be given intrathecally for brain mycoses.&lt;br /&gt;4.   Used also to decrease androgen production in women with polycystic ovary disease and cortisol production in &lt;a href="http://www.krctraining.com/CRA%20Definitions/cushing.htm"&gt;Cushing’s disease&lt;/a&gt;&lt;br /&gt;5.   Side effects&lt;br /&gt;a.    Vomiting and loss of appetite are most common.  Also seen are rash and pruritus.&lt;br /&gt;b.   Transient elevations in liver enzymes are common; full-blown hepatitis is rare but may be fatal&lt;br /&gt;6.   Toxic effects&lt;br /&gt;a.   ketoconazole inhibits synthesis of steroids and so can cause menstrual irregularities, gynecomastia, lowered libido&lt;br /&gt;b.  because of the risk of &lt;a href="http://www.krctraining.com/CRA%20Definitions/addison.htm"&gt;Addison’s disease&lt;/a&gt; due to inhibited steroidogenesis, best not to use ketoconazole in patients with burns, trauma or before surgery&lt;br /&gt;7.   Interactions&lt;br /&gt;a.  Bioavailability is decreased when given with H2 blockers or antacids – due to less acidic environment.&lt;br /&gt;b.   Rifampin and phenytoin decrease concentration of ketoconazole.&lt;br /&gt;c.   Ketoconazole increases concentrations of cyclosporine (via cytochrome P450); it also increases concentrations of terfenadine and astemizole and can cause torsades de pointes&lt;br /&gt;8.  Not recommended during pregnancy or lactation&lt;br /&gt; &lt;br /&gt;Itraconazole&lt;br /&gt;1.   Other similar antifungals are terconazole and fluconazole.&lt;br /&gt;2.   Very similar to ketoconazole with a wider range of effectiveness and fewer side effects&lt;br /&gt;3.   Uses – drug of choice for histoplasmosis (other than meningeal); also used in candidiasis, onychomycosis, ringworm and &lt;a href="http://www.krctraining.com/CRA%20Definitions/tinea_versicolor.htm"&gt;tinea versicolor&lt;/a&gt;&lt;br /&gt;4.   Given orally&lt;br /&gt;5.   Side effects – nausea, vomiting, increased blood lipids, hypokalemia, rash,&lt;br /&gt;6.   Toxic effects – adrenal insufficiency, edema of legs, hypertension&lt;br /&gt;7.   Interactions&lt;br /&gt;a.   like ketoconazole, with rifampin, phenytoin and carbamazepine; with antacids, proton pump inhibitors and H2 blockers, and with digoxin and cyclosporine&lt;br /&gt;b.   Don’t give with didanosine since it also reduces gastric acid.&lt;br /&gt; &lt;br /&gt; &lt;br /&gt;Fluconazole&lt;br /&gt;1.   Effective against &lt;a href="http://www.krctraining.com/CRA%20Definitions/candida_albicans.htm"&gt;Candida&lt;/a&gt;, Cryptococcus, Coccidioides, Histoplasma, Blastomyces, sporotrichosis, ringworm&lt;br /&gt;2.   Excellent oral absorption; also given parenterally&lt;br /&gt;3.   Uses&lt;br /&gt;a.    candidiasis&lt;br /&gt;b.   cryptococcal meningitis in AIDS patients&lt;br /&gt;c.   coccidioidal meningitis&lt;br /&gt;4.   Side effects – nausea, vomiting, headache, rash, abdominal pain, diarrhea, hair loss&lt;br /&gt;5.   Interactions&lt;br /&gt;a.   Fluconazole increases concentration of phenytoin, zidovudine, rifabutin, cyclosporine, warfarin and sulfonylureas.&lt;br /&gt;b.   Rifampin decreases fluconazole concentration, but not significantly.&lt;br /&gt; &lt;br /&gt;Griseofulvin&lt;br /&gt;1.   Effective against Microsporum, Epidermophyton and Trichopyton (dermatophytes)&lt;br /&gt;2.   Given orally; since very poor aqueous solubility given as powder&lt;br /&gt;3.   Uses – ringworm, athlete’s foot – if topical preparations have not helped&lt;br /&gt;4.   Side effects&lt;br /&gt;a.   minimal – most common is headache&lt;br /&gt;b.   less common are peripheral neuritis, fatigue, syncope, vertigo, blurry vision, confusion, nausea, vomiting, diarrhea, flatulence, leukopenia, neutropenia&lt;br /&gt;5.   Interactions – induces hepatic &lt;a href="http://www.krctraining.com/CRA%20Definitions/microsome.htm"&gt;microsomal&lt;/a&gt; enzymes&lt;br /&gt; &lt;br /&gt;Topical antifungals&lt;br /&gt;1.  Used for superficial fungal infections – candidiasis, ringworm, &lt;a href="http://www.krctraining.com/CRA%20Definitions/tinea_versicolor.htm"&gt;tinea versicolor&lt;/a&gt;, fungal keratitis, athlete’s foot&lt;br /&gt;2.   Not usually effective in fungal infections of the nails (onychomycosis) or hair&lt;br /&gt;3.   Examples are clotrimazole, econazole, miconazole, ciclopirox olamine, haloprogin, terbinafine and Nystatin&lt;br /&gt;4.   Applied to skin or inserted into the vagina; oral formulations are available for oropharyngeal candidiasis&lt;br /&gt;5.   Side effects&lt;br /&gt;a.   local reactions on skin and vagina&lt;br /&gt;b.   Systemic effects are almost non-existent.&lt;br /&gt;6.   These antifungals can be used in pregnancy.&lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt;DRUGS FOR THE TREATMENT OF HELMINTHIASIS (PARASITIC WORMS)&lt;br /&gt; &lt;br /&gt; &lt;br /&gt;Benzimidazoles&lt;br /&gt;1.      Examples are mebendazole, albendazole and thiabendazole.&lt;br /&gt;2.      Act by inhibiting microtubule polymerization&lt;br /&gt;3.      Thiabendazole has rapid oral absorption; mebendazole and albendazole are poorly absorbed.&lt;br /&gt;4.      Uses – nematodes of the GIT; albendazole is not available in the USA but in other countries is the drug of choice for cysticercosis and cystic hydatid disease.&lt;br /&gt;5.      Side effects of thiabendazole&lt;br /&gt;One.      Most common are loss of appetite, nausea, vomiting and dizziness.&lt;br /&gt;Two.    Also seen are diarrhea, fatigue, sleepiness and headache.&lt;br /&gt;6.      Mebendazole has minimal side effects.&lt;br /&gt;7.      Avoid use in patients with liver disease, potentially hepatotoxic.&lt;br /&gt;8.      Safety not established in pregnant women or children in the first two years.&lt;br /&gt; &lt;br /&gt;Praziquantel&lt;br /&gt;1.      Acts on the neuromuscular system and activates host defenses against the worms&lt;br /&gt;2.      Oral absorption is good&lt;br /&gt;3.      Effective against cestodes and trematodes (not effective against nematodes).&lt;br /&gt;4.      Uses in the USA – schistosomiasis and liver flukes&lt;br /&gt;5.      Side effects&lt;br /&gt;One.     Abdominal pain, nausea, headache, dizziness, sleepiness&lt;br /&gt;Two.    May be fever, urticaria, pruritus joint and muscle pains and eisonophilia&lt;br /&gt;Three. In CNS infections – inflammatory reactions may cause meningismus, seizures, cells in the CSF and changes in mental status&lt;br /&gt;6.      Interactions - &lt;a href="http://www.krctraining.com/CRA%20Definitions/Bioavailability.htm"&gt;bioavailability &lt;/a&gt;is reduced by carbamazepine and phenobarbital; it is increased by cimetidine and dexamethasone.&lt;br /&gt;7.      Contraindications – do not give in cases of ocular cysticercosis – may be irreversible damage.&lt;br /&gt;&lt;br /&gt;DRUGS USED IN MALARIA&lt;br /&gt; &lt;br /&gt;The malarial parasite's life cycle. Images from Purves et al., Life: The Science of Biology, 4th Edition,&lt;br /&gt; &lt;br /&gt;Chloroquine and hydroxychloroquine&lt;br /&gt;1.      Effective against all four types of malaria when in red blood cells, but not against gametocytes of Plasmodium falciparum and not against latent forms of P. ovale or P. vivax; many strains of P. falciparum are resistant to chloroquine.&lt;br /&gt;2.      Good oral absorption; also given parenterally&lt;br /&gt;3.      Uses&lt;br /&gt;One.     Malaria – chloroquine is the main drug for use in treatment and in prophylaxis&lt;br /&gt;Two.    Hydroxychloroquine is used also for mild rheumatoid arthritis, amoebic infections of the liver and systemic lupus erythematosus.&lt;br /&gt;4.      Side effects&lt;br /&gt;One.     Headache, nausea and vomiting, urticaria, blurred vision, diplopia, wide QRS&lt;br /&gt;Two.    Pruritus is common in persons with dark skin&lt;br /&gt;5.      Toxic effects&lt;br /&gt;One.     Hypotension, changes in ECG, myocardial depression and even cardiac arrest&lt;br /&gt;Two.    Ototoxicity&lt;br /&gt;Three. Retinopathy – at doses above 250 mg/day&lt;br /&gt;Four.   Myopathy, peripheral neuropathy, cardiopathy&lt;br /&gt;6.      Contraindications&lt;br /&gt;One.     Patients with hepatic, gastrointestinal, neurological or hematological disorders&lt;br /&gt;Two.    Patients with G6PD deficiency&lt;br /&gt;Three. Patients with porphyria cutanea tarda or psoriasis&lt;br /&gt;7.      Interactions – increased risk of dermatitis if given with gold or phenylbutazone&lt;br /&gt; &lt;br /&gt;Quinine&lt;br /&gt;1.      Acts on forms in the red blood cells and gametes of P. vivax and P. malariae&lt;br /&gt;2.      Given orally, intravenously or intramuscularly&lt;br /&gt;3.      Uses&lt;br /&gt;One.     Treatment of malaria due to chloroquine-resistant P. falciparum&lt;br /&gt;Two.    Blocks the action of physostigmine on muscles and is used for symptomatic treatment in myotonia congenita and in nocturnal muscle cramps.&lt;br /&gt;4.      Side effects&lt;br /&gt;One.     High levels of insulin cause hypoglycemia.&lt;br /&gt;Two.    Hypersensitivity reactions are common.&lt;br /&gt;5.      Toxic effects are called cinchonism.&lt;br /&gt;One.     Tinnitus, vertigo, headache, nausea and disturbances of vision (diplopia, photophobia, night blindness, scotomas, dilated pupils) are the first signs.&lt;br /&gt;Two.    Later, GIT disturbances (nausea, vomiting, diarrhea), sweating, flushed face and rashes appear.&lt;br /&gt;Three. Arrhythmias are also common.&lt;br /&gt;Four.   “Blackwater fever”, characterized by massive hemolysis with hemoglobinuria and hemoglobinemia, occurs in pregnant women treated with quinine or quinidine, causes anuria, renal failure and can be fatal.  It is rare.&lt;br /&gt;6.      Contraindications&lt;br /&gt;One.     Patients with myasthenia gravis (can cause dysphagia and difficulties in breathing)&lt;br /&gt;Two.    Patients with G6PD deficiency&lt;br /&gt;Three. Patients with tinnitus or optic neuritis&lt;br /&gt;7.      Interactions&lt;br /&gt;One.     Compounds containing aluminum decrease oral absorption of quinine..&lt;br /&gt;Two.    Quinine increases concentrations of digoxin and warfarin and enhances effects of neuromuscular blocking agents.  It antagonizes acetylcholinesterase inhibitors.&lt;br /&gt;Three. Cimetidine decreases renal clearance of quinine and acid urine increases it.&lt;br /&gt; &lt;br /&gt;Primaquine&lt;br /&gt;1.      Effective against hepatic and latent tissue forms of P. vivax and P. ovale&lt;br /&gt;2.      Given orally because &lt;a href="http://www.krctraining.com/CRA%20Definitions/parenteral.htm"&gt;parenteral &lt;/a&gt;administration decreases blood pressure; oral absorption is good&lt;br /&gt;3.      Uses – recurrent attacks of malaria, best given together with chloroquine&lt;br /&gt;4.      Side effects – epigastric and abdominal discomfort,&lt;br /&gt;5.      Toxic effects – methemoglobinemia, leukopenia&lt;br /&gt;6.      Contraindications&lt;br /&gt;One.     Patients with G6PD deficiency&lt;br /&gt;Two.    Patients with acute illness and risk of granulocytopenia (i.e. active rheumatoid arthritis or active systemic lupus erythematosus)&lt;br /&gt;Three. Use together with other drugs which affect hematopoiesis or hemolysis&lt;br /&gt; &lt;br /&gt;Pyrimethamine&lt;br /&gt;1.      Effective against acute attacks of falciparum malaria&lt;br /&gt;2.      Slow oral absorption&lt;br /&gt;3.      Uses&lt;br /&gt;One.     Malaria – usually in a preparation also containing a sulfonamide for synergism – mostly for chloroquine-resistant strains&lt;br /&gt;Two.    Together with sulfadiazine is used to treat toxoplasmosis&lt;br /&gt;4.      Toxic effects – megaloblastic anemia (due to folate deficiency)&lt;br /&gt; &lt;br /&gt;Halofantrine&lt;br /&gt;1.      Acts against P. falciparum in the red blood cells, but no effect on latent forms or gametocytes; most effective against mature forms&lt;br /&gt;2.      Slow oral absorption; minimally soluble in water so can’t be used parenterally&lt;br /&gt;3.      Uses&lt;br /&gt;One.     Acute attack of resistant falciparum malaria&lt;br /&gt;Two.    Should not be used for prophylaxis since its slow elimination allows development of resistant strains&lt;br /&gt;4.      Side effects – nausea, vomiting, diarrhea, abdominal pain; &lt;a href="http://www.krctraining.com/CRA%20Definitions/Pruritus.htm"&gt;pruritus &lt;/a&gt;and rash may occur in persons with dark skin&lt;br /&gt;5.      Toxic effects may occur even at low doses due to unpredictable absorption and bioavailability.  They include arrhythmias and prolonged &lt;a href="http://www.krctraining.com/CRA%20Definitions/action_potential_i.htm"&gt;QT interval&lt;/a&gt;.&lt;br /&gt; &lt;br /&gt;Mefloquine&lt;br /&gt;1.      Effective against P. falciparum&lt;br /&gt;2.      Good oral absorption; &lt;a href="http://www.krctraining.com/CRA%20Definitions/parenteral.htm"&gt;parenteral &lt;/a&gt;use causes serious local reactions&lt;br /&gt;3.      Uses – treatment and prophylaxis of chloroquine-resistant P. falciparum&lt;br /&gt;4.      Side effects&lt;br /&gt;One.     Vomiting is very common.&lt;br /&gt;Two.    Also see nausea, diarrhea, abdominal pain and mild dizziness&lt;br /&gt;5.      Toxic effects&lt;br /&gt;One.     Headache, ataxia, severe dizziness, hearing and visual disturbances are mild and self-limited.&lt;br /&gt;Two.    Seizures, encephalopathy, psychotic behavior and disorientation are more serious, but usually reversible upon stopping the drug.&lt;br /&gt;6.      Contraindications&lt;br /&gt;One.     Pregnant (especially first trimester) and nursing women&lt;br /&gt;Two.    Children less than 2 years old (or less than 15 kg body weight)&lt;br /&gt;Three. Patients with neurological or psychiatric disorders&lt;br /&gt;7.      Interactions&lt;br /&gt;One.     Increased risk of convulsions and arrhythmias if given with quinine, quinidine or chloroquine&lt;br /&gt;Two.    Increase risk of convulsions in patients treated with valproic acid&lt;br /&gt; &lt;br /&gt;Other drugs used in the treatment of malaria include sulfonamides and the tetracyclines, which are used together with the above drugs.&lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt;DRUGS USED IN OTHER PROTOZOAL DISEASES&lt;br /&gt; &lt;br /&gt;Structure of Paramecium, a typical ciliate. Image from Purves et al., Life: The Science of Biology,&lt;br /&gt; &lt;br /&gt;Metronidazole&lt;br /&gt;1.      Effective against protozoans such as Trichomonas vaginalis and Entamoeba histolytica but also against anaerobic bacteria.&lt;br /&gt;2.      Given orally, intravenously and topically to the vagina and skin&lt;br /&gt;3.      Uses&lt;br /&gt;One.     Anaerobic bacteria including Bacteroides, Clostridium and Helicobacter&lt;br /&gt;Two.    Used in the treatment of &lt;a href="http://www.krctraining.com/CRA%20Definitions/pseudomembranous_colitis.htm"&gt;pseudomembranous colitis&lt;/a&gt;&lt;br /&gt;Three. Used in Trichomonas infections in both men and women&lt;br /&gt;Four.   Used also in amebiasis and giardiasis&lt;br /&gt;4.      Side effects&lt;br /&gt;One.     Most common are headache, nausea, metallic taste in the mouth and dryness of the mouth.&lt;br /&gt;Two.    Vomiting and diarrhea may also occur.&lt;br /&gt;Three. Neutropenia may be seen and it is reversible.&lt;br /&gt;5.      Toxic effects&lt;br /&gt;One.     Dizziness, vertigo, encephalopathy, convulsions, ataxia&lt;br /&gt;Two.    Numbness or paresthesias are rare, but may not be completely reversible.&lt;br /&gt;6.      Interactions&lt;br /&gt;One.     Metronidazole’s metabolism in the liver is decreased by cimetidine and increased by phenobarbital, rifampin and prednisone.&lt;br /&gt;Two.    Avoid alcohol since metronidazole has a disulfiram effect.  Avoid disulfiram since psychosis or confusion may occur.&lt;br /&gt;7.  Use in the first trimester of pregnancy is not advised.&lt;br /&gt; &lt;br /&gt;Pentamidine&lt;br /&gt;1.      Effective against trypanosomes and Pneumocystis carinii&lt;br /&gt;2.      Given intramuscularly or intravenously for treatment; as aerosol for prophylaxis (less systemic toxicity)&lt;br /&gt;3.      Uses&lt;br /&gt;One.     Main use is for AIDS patients with Pneumocystis carinii – treatment and prophylaxis.&lt;br /&gt;Two.    Together with suramin is used in treatment of West African trypanosomiasis.&lt;br /&gt;Three. Also used in visceral leishmaniasis&lt;br /&gt;4.      Side effects – rash, thrombophlebitis and sterile abscesses at site of injection, thrombocytopenia, anemia, neutropenia, renal insufficiency&lt;br /&gt;5.      Toxic effects&lt;br /&gt;One.     Can be immediate and serious – breathlessness, increased heart rate, headache, vomiting, dizziness, syncope&lt;br /&gt;Two.    Pancreatitis, hypoglycemia or hyperglycemia and even insulin-dependent diabetes may occur&lt;br /&gt;6.  Interactions – risk of hypocalcemia if given with foscarnet&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;For more information on Clinical Research Career Training and Clinical Trials Services please contact Kriger Research Group ( &lt;a href="http://www.kriger.com/"&gt;www.kriger.com&lt;/a&gt; )  at  &lt;a href="mailto:info@kriger.com"&gt;info@kriger.com&lt;/a&gt; or call   (866) 757-9791 (USA and Canada) or + 1(416) 630-0038 (Internationally)&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/12044092-111305859054680083?l=viraltreatment.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/12044092/posts/default/111305859054680083'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/12044092/posts/default/111305859054680083'/><link rel='alternate' type='text/html' href='http://viraltreatment.blogspot.com/2005/04/drugs-for-treatment-of-viral-diseases.html' title='DRUGS FOR THE TREATMENT OF VIRAL DISEASES'/><author><name>Testimonials - Kriger Clinical Research Training</name><uri>http://www.blogger.com/profile/16932401722162313285</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry></feed>
